SkinVive FAQs

Skinvive by Juvederm is a hyaluronic acid microdroplet injectable, FDA-approved in 2023, that improves cheek skin smoothness and hydration: it is not a filler and adds no volume. It was the first injectable of its kind approved in the US, and results last about 6 months.

Skinvive is injected as many tiny droplets into the superficial layer of the skin rather than as a bolus of volume, so it changes skin quality (hydration, smoothness, light reflection), not facial shape. It is approved for improving cheek skin smoothness in adults over 21. Results build over about 4 weeks, after which retreatment is needed to maintain them. Expect injection-point bumps for a day or two, possible bruising, swelling, and tenderness. It is often called a "skin booster," and it is the only product in that category with US approval: Profhilo, its best-known European counterpart, is not FDA-approved. A June 2026 approval added neck lines; use elsewhere, including the lips, is off-label.

Profhilo is a stabilized hyaluronic acid skin booster that improves skin hydration, firmness, and quality, but it is not FDA-approved and is not available in the US. It is widely used in the UK and EU, where a course is two sessions four weeks apart. The closest US-approved alternative is Skinvive by Juvederm.

Profhilo is injected at five fixed points per side of the face, with results lasting roughly six months. European before-and-afters show subtle improvement in skin smoothness, hydration, and mild firmness, not volume or lift, and not correction of deep folds. Because it is not FDA-approved, any Profhilo offered in the US is imported outside regulatory channels, with the attendant risks of unverified sourcing and sterility. If you are in the US and want a skin-quality injectable, Skinvive is the approved option, cleared in 2023 for improving cheek skin smoothness and lasting about six months. Microneedling and laser resurfacing address similar concerns through different mechanisms. Long-term evidence for durable skin remodeling from any skin booster remains limited.

Skinvive is FDA-approved for cheek skin smoothness and, since 2026, neck lines (not the lips, so lip use is off-label), and while it can improve hydration, fine lip lines, and texture, it adds essentially no volume and will not make lips look fuller. For fullness, an HA lip filler is the correct product.

Some injectors use Skinvive superficially in the lip body or the perioral skin to soften fine vertical lines and give a smoother, more hydrated lip surface. Before-and-afters, honestly presented, show slightly glossier, less crepey lips, not a bigger lip. If fullness or shape is your goal, an HA lip filler such as Juvederm Ultra or Restylane Kysse is designed for it. Because the lips swell readily and Skinvive is placed superficially, expect more visible bumps and swelling here than in the cheeks, typically settling over several days. Off-label use is legal and common, but it means protocols are not standardized and this indication was not studied. Discuss your goals clearly with your injector before committing.

A skin booster is an injectable (usually a thin, non-crosslinked or lightly stabilized hyaluronic acid) placed in tiny droplets just under the skin to improve hydration, smoothness, and firmness, without adding volume or lift. In the US, Skinvive is the only FDA-approved product in this category.

Skin boosters treat skin quality rather than facial shape, which puts them in a different category from filler and from toxin. Skinvive by Juvederm was approved by the FDA in 2023 for improving cheek skin smoothness and lasts about six months. Other well-known boosters (Profhilo, Restylane Skinboosters, and various polynucleotide products) are used in the UK, EU, and Asia but are not FDA-approved in the US. Results are consistently subtle: better hydration and light reflection, softening of fine crepiness, and modest firmness. Long-term evidence for durable skin remodeling is limited across the category, so treat strong claims with skepticism. If your concern is volume loss, sagging, or deep folds, a filler, biostimulator, or energy device is the appropriate treatment instead.

Skinvive works by hydrating the skin from within. Tiny microdroplets of hyaluronic acid are injected superficially into the cheek skin, where the HA binds water and improves smoothness, texture, and light reflection. It adds no volume and lifts nothing. Results build over about four weeks and last around six months.

This is a skin-quality treatment, technically a hyaluronic acid microdroplet injectable rather than a filler. The product is not placed deep to create structure; it sits in the dermis, where hyaluronic acid's water-binding capacity increases hydration and improves how the skin surface reflects light: what patients describe as glow. Because the mechanism is hydration rather than volume, it does nothing for deep folds, hollow cheeks, or laxity, and the improvement is genuinely subtle. Sessions take about 20-30 minutes with topical numbing, and most people repeat treatment roughly every six months to maintain it. Skinvive is FDA-approved for cheek skin smoothness and, as of June 2026, for neck lines; lip injection is off-label. Long-term data on repeated use remain limited.

Skinvive aftercare is minimal. Expect small bumps and redness for a day or two, avoid makeup for about 12-24 hours, and skip strenuous exercise, alcohol, saunas, and direct sun or heat for 24 hours. Do not massage or pick at the injection points, and use sunscreen.

The microdroplets are placed superficially, so the visible bumps on treatment day are expected and usually flatten within 24-72 hours. Ice briefly if you are swollen, sleep on your back the first night if you can, and hold off on facials, microneedling, chemical peels, and laser for about two weeks. Results build over roughly four weeks and last around six months, so do not assess the outcome the same week. Because Skinvive is hyaluronic acid, a persistent lump can be dissolved with hyaluronidase if it does not settle: mention it to your injector rather than trying to squeeze or massage it out. Call your provider for spreading redness, warmth, fever, unusual pain, skin that looks white or dusky, or any vision change.

Skinvive causes only mild discomfort for most patients. It contains lidocaine, topical numbing cream is applied first, and the injections are shallow microdroplets, so people usually describe small pinpricks and stinging rather than pain. Treatment takes about 20-30 minutes, and soreness typically fades within a day.

Because the product is placed superficially rather than deep against bone, it tends to be one of the more comfortable injectable treatments: noticeably easier than Kybella or a structural filler. What surprises people more than pain is appearance: many small bumps and some redness are normal immediately afterward and usually flatten within 24-72 hours. Bruising is possible, particularly if you take blood thinners, fish oil, or alcohol beforehand. Ice can help, but avoid rubbing or massaging the area. Take acetaminophen if you need anything at all, which most people do not. Contact your injector for pain that worsens rather than improves, spreading redness or warmth, skin that turns white or dusky, or any change in vision.

Skinvive before-and-afters show smoother, more hydrated, more reflective cheek skin (not added volume or lift) with the change appearing over about 4 weeks and lasting roughly 6 months. It softens fine crepiness and dullness; it does not correct deep folds, hollowing, or sagging. Photos are heavily lighting-dependent.

Skinvive by Juvederm is microdroplet hyaluronic acid placed just under the skin surface, FDA-approved in 2023 to improve cheek skin smoothness in adults over 21. Because the effect is a glass-like quality of the skin rather than a change in shape, before-and-after photos are genuinely hard to capture: be skeptical of dramatic galleries. Expect small bumps at the injection points for a day or two, sometimes bruising, and swelling that resolves within a few days. Patients most likely to be happy are those with dull, dehydrated, fine-textured skin. Patients with volume loss, deep nasolabial folds, or laxity will be disappointed and are better served by filler, a biostimulator, or an energy device.

Skinvive lasts about 6 months, with results building over roughly 4 weeks after treatment and typically maintained through the six-month mark. Most patients then repeat the treatment to hold the improvement in skin smoothness and hydration. Sun exposure, smoking, and very dry skin can shorten it.

Six months is the interval supported by the FDA approval studies for cheek skin smoothness, and it is what most clinics quote. Some clinics recommend an initial series of two treatments about a month apart, then maintenance every six months; there is no strong evidence yet that repeated treatments produce cumulative, lasting change, so treat that claim cautiously. Because Skinvive improves skin quality and not shape, it is usually maintained alongside toxin or filler rather than instead of them. Budget accordingly: at $500-$900 per treatment, twice-yearly maintenance is roughly $1,000-$1,800 a year. If you find the effect too subtle for the price, microneedling or laser resurfacing target texture through a different mechanism.

Skinvive side effects are usually mild and short-lived: injection-site bumps, redness, swelling, bruising, tenderness, itching, and small firm lumps that typically resolve within a few days to a week. Because it is placed superficially in tiny microdroplets, visible bumps on the day of treatment are common and expected.

Skinvive is a hyaluronic acid microdroplet product injected into the skin rather than deep for volume, so its risk profile is lower than that of a structural filler. The most common complaint is simply looking bumpy for a day or two. Less commonly, a lump can persist; because Skinvive is hyaluronic acid, it can be dissolved with hyaluronidase if needed: an advantage over Sculptra or Radiesse. Rare risks include infection, delayed hypersensitivity nodules, and, as with any facial injectable, vascular occlusion. Skinvive is FDA-approved for cheek skin smoothness and, since June 2026, for neck lines. Lip injection is off-label. It is not recommended in pregnancy or breastfeeding, and results last around six months.

Skinvive has a favorable safety profile and is FDA-approved for cheek skin smoothness and, since June 2026, for neck lines. Side effects are usually mild bumps, redness, and swelling lasting a few days. Because it is hyaluronic acid, a problem lump can be dissolved with hyaluronidase.

Reversibility is Skinvive's real safety advantage over Sculptra and Radiesse, neither of which can be dissolved. The product is placed in microdroplets within the skin rather than deep for volume, which lowers the risk of the complications associated with structural filler, though it does not eliminate them: infection, delayed hypersensitivity nodules, and (rarely, as with any facial injectable) vascular occlusion remain possible. Severe pain, blanching or dusky skin, and any vision change are emergencies. Skinvive is not recommended in pregnancy or breastfeeding, or if you have an active skin infection at the site or a history of severe allergy or anaphylaxis. Lip injection is off-label. Have it done by a licensed, experienced injector rather than at a non-medical setting.

Skinvive typically costs $500-$900 per treatment in the US as of 2026, with most patients treating both cheeks in a single session and repeating it about every 6 months, or roughly $1,000-$1,800 a year. Prices vary by market, and some clinics recommend an initial series of two sessions.

Skinvive is usually priced per syringe or as a flat per-treatment fee, and one treatment commonly covers both cheeks. Because it is a skin-quality treatment rather than a volumizer, it is often bundled with toxin or filler, and package pricing can bring the effective cost down. Judge value against what it actually does: better hydration, smoothness, and light reflection in the cheeks, not lift, not volume, not correction of deep folds. If your concern is sagging or hollowing, spending the same money on filler or a biostimulator will serve you far better. Alternatives like microneedling or laser resurfacing address texture at comparable cost through a different mechanism.

Skinvive satisfies patients who wanted better skin hydration and smoothness in the cheeks and understood that it adds no volume; it disappoints those expecting lift, plumping, or correction of lines. Results are subtle, take about 4 weeks, and last around 6 months at $500-$900 per treatment.

The consistent theme in positive feedback is a "glass skin" quality (skin that looks more hydrated and reflects light better), and smoother makeup application. The consistent theme in negative feedback is that the change was too subtle to justify the price, particularly for patients whose real concern was volume loss or laxity, which Skinvive does nothing for. It is the only product in the skin-booster category with FDA approval in the US, which is a genuine point in its favor over grey-market alternatives. Long-term data beyond the approval studies is still limited, so claims about cumulative skin remodeling should be treated cautiously. Expect small injection bumps for a day or two and possible bruising. Choose it for skin quality, not shape.

Skinvive is worth it if you want smoother, more hydrated, better-reflecting cheek skin and understand it adds no volume and lifts nothing. At roughly $500-$900 every six months, it is a skin-quality treatment, not a filler. If you want lift or plumping, it will disappoint you.

Satisfaction with Skinvive tracks almost entirely with expectation. Patients who wanted a glassy, hydrated look in the cheeks tend to be pleased; patients who thought it would soften lines, restore volume, or replace filler tend to feel they wasted money. The effect is subtle (better texture and light reflection), and it builds over about four weeks. It also does not treat what many people are actually bothered by: deep folds, laxity, and hollowing all need different tools. Cost adds up because it is a repeating six-month expense with no cumulative structural benefit. It is FDA-approved for cheek skin smoothness and, as of June 2026, neck lines; lip use is off-label. If budget is limited, a good skincare and sun-protection routine gives you more per dollar.